Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,255 | 218 | 98.1% |
| Education | $64.37 | 20 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $535.59 | 44 | $0 (2023) |
| GlaxoSmithKline, LLC. | $466.86 | 26 | $0 (2024) |
| Novo Nordisk Inc | $412.12 | 29 | $0 (2024) |
| ABBVIE INC. | $340.42 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $248.72 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $191.27 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $164.31 | 9 | $0 (2023) |
| Allergan Inc. | $127.30 | 28 | $0 (2017) |
| Lilly USA, LLC | $110.25 | 8 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $100.98 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $356.73 | 18 | Novo Nordisk Inc ($73.87) |
| 2023 | $565.94 | 30 | GlaxoSmithKline, LLC. ($109.56) |
| 2022 | $430.16 | 28 | ABBVIE INC. ($125.80) |
| 2021 | $187.51 | 13 | AbbVie Inc. ($118.95) |
| 2020 | $270.58 | 17 | GlaxoSmithKline, LLC. ($60.97) |
| 2019 | $696.74 | 51 | PFIZER INC. ($154.06) |
| 2018 | $402.39 | 31 | PFIZER INC. ($136.29) |
| 2017 | $409.43 | 50 | Allergan Inc. ($127.30) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Vaccines | ||||||
| 11/07/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: NEUROLOGY | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.28 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Neuroscience | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: PSYCHIATRY | ||||||
| 04/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Diabetes | ||||||
| 04/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Obesity | ||||||
| 04/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Neuroscience | ||||||
| 03/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: VACCINES | ||||||
| 02/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.57 | General |
| 01/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardiology | ||||||
| 11/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Diabetes | ||||||
| 11/17/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Bone Health | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: VACCINES | ||||||
| 10/19/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 918 | 1,258 | $193,878 | $66,932 |
| 2022 | 13 | 970 | 1,334 | $179,344 | $65,917 |
| 2021 | 16 | 1,125 | 1,604 | $175,504 | $43,644 |
| 2020 | 15 | 1,117 | 1,464 | $181,272 | $43,559 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 401 | $100,250 | $31,183 | 31.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 134 | 136 | $42,840 | $15,792 | 36.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 72 | 72 | $5,400 | $5,179 | 95.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,300 | $3,102 | 94.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 19 | $8,835 | $2,668 | 30.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 74 | 77 | $3,860 | $2,263 | 58.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $6,000 | $1,838 | 30.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 260 | 328 | $14,678 | $1,741 | 11.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 11 | 11 | $1,650 | $1,413 | 85.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 15 | $2,925 | $480.78 | 16.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 11 | 11 | $660.00 | $430.98 | 65.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 98 | 105 | $1,575 | $358.05 | 22.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $840.00 | $241.22 | 28.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 25 | 31 | $465.00 | $122.14 | 26.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $600.00 | $119.90 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 443 | $90,535 | $32,426 | 35.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 109 | 109 | $30,250 | $12,863 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $15,900 | $7,137 | 44.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 90 | 92 | $8,030 | $6,285 | 78.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 89 | 91 | $3,090 | $2,536 | 82.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 266 | 324 | $23,004 | $1,880 | 8.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 23 | 28 | $3,535 | $1,368 | 38.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 26 | 30 | $1,500 | $364.41 | 24.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 96 | 99 | $1,480 | $336.24 | 22.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $370.00 | $308.70 | 83.4% |
About Dr. C Holmes, MD
Dr. C Holmes, MD is a Family Medicine healthcare provider based in Alma, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568488054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. C Holmes, MD has received a total of $3,319 in payments from pharmaceutical and medical device companies, with $356.73 received in 2024. These payments were reported across 238 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,255).
As a Medicare-enrolled provider, Holmes has provided services to 4,130 Medicare beneficiaries, totaling 5,660 services with total Medicare billing of $220,053. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Alma, MI
- Active Since 07/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568488054
Products in Payments
- Ozempic (Drug) $218.89
- ENTRESTO (Drug) $191.27
- CHANTIX (Drug) $184.91
- XARELTO (Drug) $163.70
- BEXSERO (Biological) $126.55
- UBRELVY (Drug) $114.41
- MYRBETRIQ (Drug) $113.74
- PREVNAR - 13 (Biological) $112.46
- VRAYLAR (Drug) $107.76
- TRELEGY ELLIPTA (Drug) $102.31
- JANUVIA (Drug) $88.12
- AREXVY (Drug) $81.33
- QULIPTA (Drug) $79.04
- VIBERZI (Drug) $71.35
- ANORO (Drug) $64.36
- MOUNJARO (Drug) $62.53
- ELIQUIS (Drug) $59.74
- Veozah (Drug) $50.57
- SHINGRIX (Biological) $50.24
- Tresiba (Drug) $49.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Alma
Dr. Jeffrey Medlock, M.d, M.D
Family Medicine — Payments: $2,835
Christina Downer, D.o, D.O
Family Medicine — Payments: $2,044
Dr. Thanh Le
Family Medicine — Payments: $1,572
Javed Rana, M.d, M.D
Family Medicine — Payments: $1,392
Robert Bishop, M. D, M. D
Family Medicine — Payments: $1,385
Dr. Ian Furtado, M.d, M.D
Family Medicine — Payments: $1,167